Filing Details

Accession Number:
0001179110-13-012615
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-02 17:47:46
Reporting Period:
2013-08-01
Filing Date:
2013-08-02
Accepted Time:
2013-08-02 17:47:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1436304 Kythera Biopharmaceuticals Inc KYTH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559531 E Nathaniel David C/O Kythera Biopharmaceuticals, Inc.
27200 West Agoura Road, Suite 200
Calabasas CA 91301
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-08-01 3,301 $26.76 536,135 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 9, 2014.
  2. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $26.53 to $27.00, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.